Dr. Neil Adrian Zakai MD
Hematologist-Oncologist | Hematology & Oncology
Given Building E214 Univer Burlington VT, 05405Rating
4/5
About
Dr. Neil Zakai is a hematologist oncologist practicing in Burlington, VT. Dr. Zakai specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Internal MedicineAmerican Board of Internal MedicineABIM- Hematology- 2007
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score.
- ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE).
- Activated partial thromboplastin time and risk of future venous thromboembolism.
- Common hemostasis and inflammation gene variants and venous thrombosis in older adults from the Cardiovascular Health Study.
- Racial disparities in awareness and treatment of atrial fibrillation: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.
- Total tissue factor pathway inhibitor and venous thrombosis. The Longitudinal Investigation of Thromboembolism Etiology.
- Racial differences in venous thromboembolism.
- Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States.
- Why is my patient anemic?
- Persistence and remission of musculoskeletal pain in community-dwelling older adults: results from the cardiovascular health study.
- Population approaches to improve diet, physical activity, and smoking habits: a scientific statement from the American Heart Association.
- Near-elimination of folate-deficiency anemia by mandatory folic acid fortification in older US adults: Reasons for Geographic and Racial Differences in Stroke study 2003-2007.
- N-terminal pro-B-type natriuretic peptide and stroke risk: the reasons for geographic and racial differences in stroke cohort.
- Validating laboratory results in a national observational cohort study without field centers: the Reasons for Geographic and Racial Differences in Stroke cohort.
- ABO blood type, factor VIII, and incident cognitive impairment in the REGARDS cohort.
Treatments
- Bone Marrow Biopsy
Fellowships
- Brown University School of Medicine - Hematology/Oncology
Dr. Neil Adrian Zakai MD's Practice location
Neil Zakai
Given Building E214 Univer -Burlington, VT 05405Get Direction
Dr. Neil Adrian Zakai MD's reviews
Write ReviewPatient Experience with Dr. Zakai
Recommended Articles
![]()
The Promising Future of Gene Therapy and LymphomaNon-Hodgkin lymphoma affects over 700,000 people in America alone. Though current treatments are moderately effective, especially for aggressive forms of the disease, more can be done to help people impacted by NHL. Researchers are doing just that by working to develop new, innovative treatment for...
![]()
Survey Shows Lack of Blood Cancer Knowledge Among AmericansIf anyone is asked to describe what cancer is, chances are they’ll be able to provide at least a rough definition of the disease. Generally speaking, cancer is the name for the rapid and uncontrollable development of cells in a certain part of the body. In addition to holding a general awareness...
![]()
How Immunotherapy Makes a Real Difference in Relapsed Hodgkin LymphomaHodgkin lymphoma, which affects about 0.2% of the people in the United States, is often treated using a combination of chemotherapy, radiation therapy, and stem cell transplant. Sometimes these treatments fail to halt the progress of the disease, and in other cases the cancer seems to halt but then...
![]()
Breaking News on the Treatment of Follicular LymphomaReuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...
![]()
'Sophie the Brave' Fights Childhood T-Cell LymphomaThe story of 2-year-old Sophie Skiles and her arduous battle with T-cell lymphoma pulls at one’s heartstrings while also causing one to marvel at the faith of her Mom, Shelby.The public first learned of Sophie when a newscast about her was posted online October 20, 2017. (KLTB/abc) It soon made it...
![]()
'Robocop' Stem Cells Developed to Fight CancerCancer is the second-leading cause of death in the United States, although due to several advancements in cancer screening and treatment, survival rates have begun to improve.A new cancer therapyResearchers at the University of Minnesota and Mayo Clinic have developed a new type of cancer therapy...
Nearby Providers
![]()
Dr. Steven P Emmons MDUvm Hematology Oncology Burlington VT 05405![]()
Dr. Kim Lynnette Dittus MD, PHD89 Beaumont Ave Burlington VT 05405![]()
Mr. Gurpreet Singh Lamba M.B.B.S.89 BEAUMONT AVE BURLINGTON VT 05405![]()
Dr. Margaret Kennedy MDHEMATOLOGY ONCOLOGY 89 BEAUMONT AVE BURLINGTON VT 05405
Nearest Hospitals
UNIVERSITY OF VERMONT MEDICAL CENTERl
111 COLCHESTER AVE BURLINGTON VT 5401NORTHWESTERN MEDICAL CENTER INCl
133 FAIRFIELD STREET SAINT ALBANS VT 5478